Publication | Closed Access

A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy

Hematological MalignancyLymphoid NeoplasiaMedicineHematologyImmunologyPathologySingle DoseHigh-dose ChemotherapyMalignant Lymphoma PatientsOncologyRadiation OncologyCancer ResearchHealth Sciences